Want to stay updated on the latest news?
Create a Reader Account today to follow the industries and companies that interest you, and customize your news dashboard. SIGN INTO READER ACCOUNT CREATE READER ACCOUNT
Covid-19 Vaccine Market Is Witnessing A Higher Pace Due To The Rise In The Number Of Patients - Report By Acumen Research And Consulting
March 25, 2021 11:57 ET
|
Acumen Research and Consulting
Acumen Research and Consulting, a global provider of market research studies, recently added a forthcoming report titled “Covid-19 Vaccine Market – Global Industry Analysis, Market Size, Opportunities...
Medolife Rx Announces Positive Results in Clinical Safety Study on Its Polarized Drug Candidate for the Treatment of COVID-19
March 18, 2021 08:30 ET
|
Quanta, Inc.
BURBANK, Calif., March 18, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Medolife Rx, Inc. ("Medolife"), a global integrated bioceutical company with R&D, manufacturing, and consumer product...
University of Minnesota Medical School launches clinical trial studying metformin treatment for COVID-19
March 15, 2021 09:54 ET
|
University of Minnesota Medical School
Minneapolis / St. Paul, March 15, 2021 (GLOBE NEWSWIRE) -- A new multi-site clinical trial led by the University of Minnesota Medical School is studying the effectiveness of metformin, a generic...
COVID-19 Treatment Market Is Anticipated To Grow With Moderate CAGR During The Forecast Period 2020 – 2027: Acumen Research And Consulting
February 02, 2021 11:11 ET
|
Acumen Research and Consulting
LOS ANGELES, Feb. 02, 2021 (GLOBE NEWSWIRE) -- According to Acumen Research and Consulting, the Global Covid-19 Treatment Market is anticipated to grow with moderate CAGR during the forecast period...
Relay Medical and Glow LifeTech Report on Successful Phase II Clinical Results For COVID-19 Treatment Candidate Based On Its MyCell Technology™
January 14, 2021 16:15 ET
|
Relay Medical Corp.
Glow LifeTech has the exclusive rights for MyCell Technology™ in the United States, Canada and Mexico for one of the primary ingredients used in ArtemiC™, a COVID-19 Treatment Candidate with...
Beroni Group Named as a Top Infection Control Solutions Company in APAC for 2020
November 09, 2020 08:30 ET
|
Beroni Group Limited
NEW YORK and SYDNEY, Australia, Nov. 09, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based diversified biopharmaceutical enterprise...
Beroni Group Announces Successful Completion of SARS-CoV-2 Pseudovirus Neutralization Assay for Treatment of COVID-19
October 19, 2020 08:53 ET
|
Beroni Group Limited
NEW YORK and SYDNEY, Australia, Oct. 19, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based diversified biopharmaceutical enterprise,...
Renibus Therapeutics’ COVID-19 Treatment, RBT-9, Shows Antiviral Activity Against SARS-CoV-2 In Vitro
October 07, 2020 09:00 ET
|
Rénibus Therapeutics Inc.
DALLAS, Texas, Oct. 07, 2020 (GLOBE NEWSWIRE) -- Renibus Therapeutics, Inc., a clinical-stage biotechnology company, announced today that its investigational treatment for COVID-19, RBT-9, has...
Broward Health Medical Center Becomes First Clinical Site in U.S. for Phase II Trial for LSALT Peptide
July 28, 2020 08:13 ET
|
Arch Biopartners
TORONTO, July 28, 2020 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), a clinical stage company developing new drug candidates for treating...
Renibus Therapeutics Receives FDA Fast Track Designation for RBT-9 Treatment in COVID-19
June 23, 2020 09:00 ET
|
Rénibus Therapeutics Inc.
DALLAS, Texas, June 23, 2020 (GLOBE NEWSWIRE) -- Renibus Therapeutics, Inc., a clinical-stage biotechnology company, announced today that it has been granted Fast Track designation by the FDA for...